This is a delivery order awarded by the Department of Veterans Affairs (VA) to Insmed Inc., a global biopharmaceutical company, for the provision of emergency pharmacy orders. The order, valued at $70,737.80, is for firm fixed-price pharmaceutical products to be delivered by September 30, 2025. The contract is not set aside for any particular business type. Insmed Inc. holds multiple federal contract vehicles with the VA, including a GSA Pharmaceutical and Drugs schedule contract, which allows it to provide critical medications like the antibiotic amikacin and the inhalation medication ARIKAYCE to VA medical centers as needed.
Generated 3/23/25, 12:49 AM